MEF2A and coronary artery disorder: Accordingly, we became curious about possible MEF2A involvement in vascular endothelial cell (VEC) aging by regulating the PI3K pathway, and whether the plasma levels of MEF2A can indicate risk of cardiovascular diseases such as CAD.